These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9856996)

  • 21. Effect of covalent antithrombin-heparin on activated protein C inactivation by protein C inhibitor.
    Van Walderveen MC; Berry LR; Chan AK
    J Biochem; 2010 Aug; 148(2):255-60. PubMed ID: 20538715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism by which exosites promote the inhibition of blood coagulation proteases by heparin-activated antithrombin.
    Izaguirre G; Swanson R; Raja SM; Rezaie AR; Olson ST
    J Biol Chem; 2007 Nov; 282(46):33609-33622. PubMed ID: 17875649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surface modification of polydimethylsiloxane with a covalent antithrombin-heparin complex to prevent thrombosis.
    Leung JM; Berry LR; Chan AK; Brash JL
    J Biomater Sci Polym Ed; 2014; 25(8):786-801. PubMed ID: 24735089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of factor IXa inhibition by antithrombin in the presence of unfractionated and low molecular weight heparins and fucoidan.
    Mauray S; de Raucourt E; Talbot JC; Dachary-Prigent J; Jozefowicz M; Fischer AM
    Biochim Biophys Acta; 1998 Sep; 1387(1-2):184-94. PubMed ID: 9748565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravascular targeting of a new anticoagulant heparin compound.
    Van Walderveen MC; Berry LR; Chan AK
    Cardiovasc Hematol Disord Drug Targets; 2009 Jun; 9(2):149-58. PubMed ID: 19519374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemical-physical characterization of polyurethane catheters modified with a novel antithrombin-heparin covalent complex.
    Du YJ; Berry LR; Chan AK
    J Biomater Sci Polym Ed; 2011; 22(17):2277-94. PubMed ID: 21092417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Skeletal muscle myosin and cardiac myosin attenuate heparin's antithrombin-dependent anticoagulant activity.
    Morla S; Deguchi H; Griffin JH
    J Thromb Haemost; 2021 Feb; 19(2):470-477. PubMed ID: 33176060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isoform composition of antithrombin in a covalent antithrombin-heparin complex.
    Chan AK; Berry LR; Paredes N; Parmar N
    Biochem Biophys Res Commun; 2003 Oct; 309(4):986-91. PubMed ID: 13679071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging anticoagulants: mechanism of action and future potential.
    Klement P; Rak J
    Vnitr Lek; 2006 Mar; 52 Suppl 1():119-22. PubMed ID: 16637459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-thrombin activities of heparin. Effect of saccharide chain length on thrombin inhibition by heparin cofactor II and by antithrombin.
    Bray B; Lane DA; Freyssinet JM; Pejler G; Lindahl U
    Biochem J; 1989 Aug; 262(1):225-32. PubMed ID: 2818566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood-compatible biomaterials by surface coating with a novel antithrombin-heparin covalent complex.
    Klement P; Du YJ; Berry L; Andrew M; Chan AK
    Biomaterials; 2002 Jan; 23(2):527-35. PubMed ID: 11762330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding of heparin to plasma proteins and endothelial surfaces is inhibited by covalent linkage to antithrombin.
    Chan AK; Paredes N; Thong B; Chindemi P; Paes B; Berry LR; Monagle P
    Thromb Haemost; 2004 May; 91(5):1009-18. PubMed ID: 15116263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heparin enhances the specificity of antithrombin for thrombin and factor Xa independent of the reactive center loop sequence. Evidence for an exosite determinant of factor Xa specificity in heparin-activated antithrombin.
    Chuang YJ; Swanson R; Raja SM; Olson ST
    J Biol Chem; 2001 May; 276(18):14961-71. PubMed ID: 11278930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of ternary complexes, in which heparin binds both antithrombin and proteinase, in the acceleration of the reactions between antithrombin and thrombin or factor Xa.
    Danielsson A; Raub E; Lindahl U; Björk I
    J Biol Chem; 1986 Nov; 261(33):15467-73. PubMed ID: 3782075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of a novel covalent antithrombin-heparin complex on thrombin generation on fetal distal lung epithelium.
    Chan AK; Berry L; Mitchell L; Baranowski B; O'Brodovich H; Andrew M
    Am J Physiol; 1998 Jun; 274(6):L914-21. PubMed ID: 9609730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interactions of heparin and a covalently-linked antithrombin-heparin complex with components of the fibrinolytic system.
    Chander A; Atkinson HM; Stevic I; Berry LR; Kim PY; Chan AK
    Thromb Haemost; 2013 Dec; 110(6):1180-8. PubMed ID: 24048327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of covalent serpin-heparinoid complexes on plasma thrombin generation on fetal distal lung epithelium.
    Berry LR; Klement P; Andrew M; Chan AK
    Am J Respir Cell Mol Biol; 2003 Feb; 28(2):150-8. PubMed ID: 12540482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biodistribution of covalent antithrombin-heparin complexes.
    Chindemi PA; Klement P; Konecny F; Berry LR; Chan AK
    Thromb Haemost; 2006 Apr; 95(4):629-36. PubMed ID: 16601833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antithrombin supplementation attenuates heparin resistance in plasma spiked with Gla-domainless factor Xa S195A in vitro.
    Mishima Y; Butt AL; Vandyck KB; Levy JH; Stewart KE; Tanaka KA
    Br J Anaesth; 2024 Jun; 132(6):1204-1210. PubMed ID: 38594117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein adsorption on polyurethane catheters modified with a novel antithrombin-heparin covalent complex.
    Du YJ; Brash JL; McClung G; Berry LR; Klement P; Chan AK
    J Biomed Mater Res A; 2007 Jan; 80(1):216-25. PubMed ID: 17072855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.